Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease

Gorog, Diana A. ; Erik Lerkevang Grove ; et al.

In: European Heart Journal, 42(23), 2265-2269. Oxford University Press Ten Berg, J, Sibbing, D, Rocca, B, Van Belle, E, Chevalier, B, Collet, J-P, Dudek, D, Gilard, M, Gorog, D A, Grapsa, J, Grove, E L, Lancellotti, P, Petronio, A S, Rubboli, A, Torracca, L, Vilahur, G, Witkowski, A & Mehilli, J 2021, ' Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation : a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease ', European Heart Journal, vol. 42, no. 23, pp. 2265-2269 https://doi.org/10.1093/eurheartj/ehab196 European Heart Journal European Heart Journal, 2021, 42 (23), pp.2265-2269. ⟨10.1093/eurheartj/ehab196⟩; (2021-06-14) S. 2265-2269

Online unknown

Wie komme ich dran?

Zugriff:

View record in OpenAIRE (Volltext)

Transcatheter aortic valve implantation (TAVI) is effective in older patients with symptomatic severe aortic stenosis, while the indication has recently broadened to younger patients at lower risk. Although thromboembolic and bleeding complications after TAVI have decreased over time, such adverse events are still common. The recommendations of the latest 2017 ESC/EACTS Guidelines for the management of valvular heart disease on antithrombotic therapy in patients undergoing TAVI are mostly based on expert opinion. Based on recent studies and randomized controlled trials, this viewpoint document provides updated therapeutic insights in antithrombotic treatment during and after TAVI.

Titel:	Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease
Autor/in / Beteiligte Person:	Gorog, Diana A. ; Erik Lerkevang Grove ; Dudek, Dariusz ; Rubboli, Andrea ; Mehilli, Julinda ; Jurriën M. ten Berg ; Vilahur, Gemma ; Grapsa, Julia ; Torracca, Lucia ; Rocca, Bianca ; Witkowski, Adam ; Anna Sonia Petronio ; Eric Van Belle ; Lancellotti, Patrizio ; Collet, Jean-Philippe ; Sibbing, Dirk ; Gilard, Martine ; Chevalier, Bernard ; Cardiologie ; RS: Carim - B04 Clinical thrombosis and Haemostasis ; St. Antonius Hospital [Nieuwegein] ; Ludwig-Maximilians-Universität München [LMU] ; German Center for Cardiovascular Research [DZHK] ; Università cattolica del Sacro Cuore = Catholic University of the Sacred Heart [Roma] [Unicatt] ; Institut Coeur Poumon [CHU Lille] ; Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires [RNMCD - U1011] ; Hôpital Privé Jacques Cartier [Massy] ; CHU Pitié-Salpêtrière [AP-HP] ; Action, Groupe ; Hôpital de la Cavale Blanche ; Université de Brest [UBO] ; Imperial College London ; University of Hertfordshire [Hatfield] [UH] ; Aarhus University Hospital ; Centre Hospitalier Universitaire de Liège [CHU-Liège] ; University of Pisa - Università di Pisa ; Hospital de la Santa Creu i Sant Pau ; Cardiovascular Research Institute Maastricht (CARIM) ; Maastricht University [Maastricht] ; Ludwig-Maximilians-Universität München (LMU) ; German Center for Cardiovascular Research (DZHK) ; Berlin Institute of Health (BIH) ; Università cattolica del Sacro Cuore = Catholic University of the Sacred Heart [Roma] (Unicatt) ; Lille, CHU ; Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille) ; Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U1011 (RNMCD) ; Institut Pasteur de Lille ; Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille) ; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU) ; Institut de cardiologie [CHU Pitié-Salpêtrière] ; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP] ; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU) ; Sorbonne Université (SU) ; Jagiellonian University - Medical College (JUMC) ; Uniwersytet Jagielloński w Krakowie = Jagiellonian University (UJ) ; Maria Cecilia Hospital [Cotignola] ; Université de Brest (UBO) ; University of Hertfordshire [Hatfield] (UH) ; Guy's and St Thomas' NHS Foundation Trust [London, UK] ; Centre Hospitalier Universitaire de Liège (CHU-Liège) ; National Institute of Cardiology [Varsovie, Pologne]
Link:	View record in OpenAIRE (Volltext) https://cris.maastrichtuniversity.nl/en/publications/71e2b11b-4efb-4bcf-9028-7c4d0539e381
Quelle:	European Heart Journal, 42(23), 2265-2269. Oxford University Press Ten Berg, J, Sibbing, D, Rocca, B, Van Belle, E, Chevalier, B, Collet, J-P, Dudek, D, Gilard, M, Gorog, D A, Grapsa, J, Grove, E L, Lancellotti, P, Petronio, A S, Rubboli, A, Torracca, L, Vilahur, G, Witkowski, A & Mehilli, J 2021, ' Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation : a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease ', European Heart Journal, vol. 42, no. 23, pp. 2265-2269 https://doi.org/10.1093/eurheartj/ehab196 European Heart Journal European Heart Journal, 2021, 42 (23), pp.2265-2269. ⟨10.1093/eurheartj/ehab196⟩; (2021-06-14) S. 2265-2269
Veröffentlichung:	2021
Medientyp:	unknown
ISSN:	0195-668X (print) ; 1522-9645 (print)
Schlagwort:	medicine.medical_specialty Percutaneous Consensus Settore BIO/14 - FARMACOLOGIA [SDV]Life Sciences [q-bio] Heart Valve Diseases 030204 cardiovascular system & hematology Lower risk law.invention Transcatheter Aortic Valve Replacement 03 medical and health sciences 0302 clinical medicine Antithrombotic treatment Transcatheter aortic valve implantation Aged Aortic Valve Fibrinolytic Agents Humans Treatment Outcome Aortic Valve Stenosis Heart Valve Prosthesis Implantation Thrombosis Randomized controlled trial law Internal medicine Antithrombotic medicine 030212 general & internal medicine Adverse effect Aortic Valve/surgery ANTIPLATELET THERAPY business.industry Fibrinolytic Agents/therapeutic use valvular heart disease Thrombosis/drug therapy medicine.disease Stenosis Aortic Valve Stenosis/drug therapy Transcatheter Aortic Valve Replacement/adverse effects Cardiology Cardiology and Cardiovascular Medicine business
Sonstiges:	Nachgewiesen in: OpenAIRE Sprachen: English File Description: application/octet-stream Language: English Rights: OPEN

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.